Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.84 |
| ▸ | CA1 | P00915 | 3/20 | 0.84 |
| ▸ | CA7 | P43166 | 3/20 | 0.84 |
| ▸ | CA9 | Q16790 | 3/20 | 0.84 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.84 |
| ▸ | RELA | Q04206 | 1/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.70 |
| ▸ | APEX1 | P27695 | 2/20 | 0.70 |
| ▸ | RECQL | P46063 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | PLK1 | P53350 | 2/20 | 0.66 |
| ▸ | BACE1 | P56817 | 2/20 | 0.66 |
| ▸ | PLK4 | O00444 | 1/20 | 0.66 |
| ▸ | IKBKB | O14920 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL941424 | 0.91 | RELA (1.00) | CA12CA1CA7CA9CA13 | |
| SCHEMBL30608638 | 0.91 | RELA (1.00) | CA12CA1CA7CA9CA13 | |
| SCHEMBL2355138 | 0.90 | KDM4E (0.88) | CA12CA1CA7CA9CA13 | |
| SCHEMBL38658338 | 0.89 | CA12 (0.84) | CA12CA1CA7CA9CA13 | |
| SCHEMBL3796697 | 0.88 | CA12 (0.82) | CA12CA1CA7CA9CA13 | |
| SCHEMBL941032 | 0.83 | KDM4E (1.00) | CA12CA1CA7CA9CA13 | |
| SCHEMBL29508368 | 0.83 | KDM4E (1.00) | CA12CA1CA7CA9CA13 | |
| SCHEMBL16401447 | 0.82 | KDM4E (0.65) | CA12CA1CA7CA9CA13 | |
| Ellagic Acid SCHEMBL28824363 | 0.81 | KDM4E (0.92) | CA12CA1CA7CA9CA13 | |
| Ellagic Acid SCHEMBL1645767 | 0.81 | KDM4E (1.00) | CA12CA1CA7CA9CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130324595-A1 | C-GLUCOSIDIC ELLAGITANNIN COMPOUNDS FOR USE FOR ALTERING THE SUPRAMOLECULAR ARRANGEMENT OF ACTIN AND FOR THE TREATMENT OF OSTEOPOROSIS, CANCER, BACTERIAL INFECTION AND VIRAL INFECTION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2013-12-05 | — | — | US | claimed |
| WO-2012113835-A1 | C-GLUCOSIDIC ELLAGITANNIN COMPOUNDS FOR USE FOR ALTERING THE SUPRAMOLECULAR ARRANGEMENT OF ACTIN AND FOR THE TREATMENT OF OSTEOPOROSIS, CANCER, BACTERIAL INFECTION AND VIRAL INFECTION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2012-08-30 | — | — | WO | claimed |
| CN-102485231-A | Discocleidion sufescens Pax et Hoffm. extract, preparation method thereof and purpose thereof | UNIV NANJING CHINESE MEDICINE | 2012-06-06 | — | — | CN | claimed |
| JP-11322569-A | — | — | None | — | — | JP | disclosed |
| JP-11292752-A | — | — | None | — | — | JP | disclosed |
| JP-9202711-A | — | — | None | — | — | JP | disclosed |
| WO-2024126540-A1 | COSMETIC COMPOSITION COMPRISING NIACINAMIDE, A GINGER ROOT EXTRACT, A CARBOXYLIC ACRYLIC POLYMER, AN ACTIVE AGENT FOR COMBATING HAIR LOSS AND/OR AN ANTI-DANDRUFF ACTIVE AGENT | L'OREAL (FR) | 2024-06-20 | — | — | WO | disclosed |
| US-10772822-B2 | Molecularly imprinted polymers and their use as antidandruff agents | L'OREAL (FR) | 2020-09-15 | — | — | US | disclosed |
| US-10555890-B2 | Flexible solid cosmetic composition comprising anionic surfactants and solid particles, and cosmetic treatment process | L'OREAL (FR) | 2020-02-11 | — | — | US | disclosed |
| US-10548832-B2 | Flexible solid cosmetic composition comprising anionic surfactants and polymer conditioning agents, and cosmetic treatment method | L'OREAL (FR) | 2020-02-04 | — | — | US | disclosed |
| US-20190125655-A1 | MOLECULARLY IMPRINTED POLYMERS OF SOL-GEL TYPE AND THEIR USE AS ANTIDANDRUFF AGENT | L'OREAL (FR) | 2019-05-02 | — | — | US | disclosed |
| JP-2000247863-A | COMPOSITION FOR EXTERNAL USE FOR SKIN | LION CORP | 2000-09-12 | — | — | JP | disclosed |
| US-6066312-A | SKIN-LIGHTENING AND WHITENING EFFECTS | LION CORPORATION (JP) | 2000-05-23 | — | — | US | disclosed |
| JP-H11322569-A | COMPOSITION FOR EXTERNAL USE FOR SKIN | LION CORP | 1999-11-24 | — | — | JP | disclosed |
| JP-H11292752-A | BEAUTIFULLY WHITENING AGENT AND COMPOSITION FOR EXTERNAL USE FOR SKIN | LION CORP | 1999-10-26 | — | — | JP | disclosed |
| JP-H09202711-A | BEAUTIFYING AND WHITENING AGENT AND EXTERNAL PREPARATION COMPOSITION | LION CORP | 1997-08-05 | — | — | JP | disclosed |
| US-5141741-A | Calcium, barium, magnesium salt of ellagic acid | LION CORPORATION (JP) | 1992-08-25 | — | — | US | disclosed |
| EP-0294808-B1 | AGENT FOR EXTERNAL APPLICATION AND USE THEREOF | LION CORPORATION (JP) | 1992-04-22 | — | — | EP | disclosed |
| US-5073545-A | Cosmetic whitening or lightening of human skin | LION CORPORATION (JP) | 1991-12-17 | — | — | US | disclosed |
| EP-0294808-A1 | Agent for external application and use thereof | LION CORPORATION (JP) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10772822-B2 | Molecularly imprinted polymers and their use as antidandruff agents | DNMT1, POLR1C, ETF1 | CA12 959/4885CA1 1695/4885CA7 1662/4885 |
| US-10548832-B2 | Flexible solid cosmetic composition comprising anionic surfactants and polymer conditioning agents, and cosmetic treatment method | KRT18, CUTA, MUC1 | CA12 376/4885CA1 1140/4885CA7 630/4885 |
| US-10555890-B2 | Flexible solid cosmetic composition comprising anionic surfactants and solid particles, and cosmetic treatment process | CUTA, KRT18, KAT7 | CA12 303/4885CA1 795/4885CA7 354/4885 |
| US-20190125655-A1 | MOLECULARLY IMPRINTED POLYMERS OF SOL-GEL TYPE AND THEIR USE AS ANTIDANDRUFF AGENT | POF1B, PIK3C3, DNMT1 | CA12 613/4885CA1 637/4885CA7 1366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.